Affinity chromatography wash buffer
A wash buffer comprising greater than 0 mM and less than about 500 mM arginine, greater than 0 mM and less than about 250 mM guanidine, greater than 0 mM and less than about 250 mM sodium chloride, and greater than 0 mM and less than about 50 mM of an anionic surfactant, or greater than 0% and less than about 0.25% w/v of a non-ionic surfactant. When used during affinity chromatography purification of a protein of interest, such as an antibody, the wash buffer significantly reduces the level of host cell proteins from the preparation. Following affinity chromatography with the wash buffer, the protein of interest may be further purified using membrane chromatography.
1. A method of preparing a purified protein of interest, comprising loading a mixture comprising a protein of interest and one or more contaminant proteins onto an affinity chromatography ligand, washing the ligand with an aqueous wash solution comprising arginine and guanidine to elute the one or more contaminant proteins from the ligand, and then eluting the protein of interest from the ligand, thereby forming a purified eluate of the protein of interest, wherein the protein of interest is an antibody.
2. The method according to claim 1 , wherein the affinity chromatography ligand comprises Protein A.
3. The method of claim 1 , further comprising lowering the pH of the purified eluate of the protein of interest for a period of time sufficient to inactivate viruses.
4. The method of claim 1 , further comprising filtering the purified eluate of the protein of interest to remove viruses.
5. The method of claim 1 , further comprising loading the purified eluate of the protein of interest onto a membrane chromatography support and collecting flow through comprising a further-purified eluate from the membrane chromatography support.
6. The method of claim 1 , further comprising formulating the purified eluate of the protein of interest as a composition including a pharmaceutically acceptable excipient.
7. The method according to claim 5 , further comprising formulating the further-purified eluate of the protein of interest as a composition including a pharmaceutically acceptable excipient.
8. The method of claim 2 wherein the aqueous wash solution increases viral clearance from the mixture as measured by a virus log reduction value (LRV).
9. The method of claim 1 , wherein the solution comprises: greater than 0 mM and less than about 200 mM arginine and from about 50 mM to about 250 mM guanidine.
10. The method of claim 9 , wherein the solution comprises from about 50 mM to about 150 mM arginine.
11. The method of claim 9 , wherein the solution comprises from about 75 mM to about 125 mM arginine.
12. The method of claim 9 , wherein the solution comprises from about 100 mM guanidine to about 200 mM guanidine.
13. The method of claim 9 , wherein the solution comprises from about 150 mM guanidine to about 200 mM guanidine.
14. The method of claim 1 , wherein the combined guanidine and arginine concentration is >175 mM.
15. The method of claim 9 , wherein the combined guanidine and arginine concentration is >175 mM.
16. The method of claim 9 , wherein the solution comprises 50-100 mM arginine, 100-250 mM guanidine, and 25 mM sodium octanoate.
17. The method of claim 1 , wherein the solution further comprises an anionic surfactant.
18. The method of claim 17 , wherein the anionic surfactant comprises sodium octanoate.
19. The method of claim 1 , wherein the solution further comprises sodium chloride.
20. The method of claim 1 , wherein the solution comprises a pH of about 7.5.